Contact this trialFirst, we need to learn more about you.
Hormone Therapy
FOR46 + Enzalutamide for Prostate Cancer
Recruiting1 awardPhase 1 & 2
San Francisco, California
This trial is testing a new drug, FOR46, combined with enzalutamide in patients with advanced prostate cancer that hasn't responded to other treatments. FOR46 targets cancer cells directly, and enzalutamide blocks hormones that help the cancer grow. Enzalutamide is approved for the treatment of advanced prostate cancer and has shown effectiveness in prolonging survival.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.